Disease/Infection News

RSS

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Researchers in Italy have shown that leaf extract from the common grapevine – Vitis vinifera – exhibits significant antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

1 Jul 2021

FDA's new Cyclospora Prevention, Response and Research Action Plan released

As part of our ongoing efforts to combat foodborne illness and aligned with our New Era of Smarter Food Safety initiative, today, the U.S. Food and Drug Administration released the Cyclospora Prevention, Response and Research Action Plan.

1 Jul 2021

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

In a recently published article scientists have provided a detailed description of the utility of mannose-specific lectins in preventing coronavirus infections. They have specifically explained how mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of viral spike protein and how such interactions can be medically utilized to control coronavirus transmission.

1 Jul 2021

Study evaluates neutralizing antibody responses elicited by the Pfizer/BioNTech COVID-19 vaccine

A recent Diagnostics study discusses the specific antibody response that occurred in individuals after they had received the SARS-CoV-2 vaccine.

1 Jul 2021

Can age, sex, BMI or blood group influence the immunogenicity of the Pfizer/BioNTech COVID-19 vaccine?

A group of Belgium researchers recently discuss their findings in the journal Microorganisms, which describe the influence of several factors on vaccine-induced immunogenicity.

1 Jul 2021

Could peridomestic mammals act as zoonotic reservoirs for SARS-CoV-2?

In new research from researchers in the USA and Australia peridomestic mammals, which live in and around human habitations, have been investigated to ascertain how SARS-CoV-2 can affect species external to, but in close proximity to, the human population.

1 Jul 2021

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents for humans, animals, and plants, today announced a non-exclusive license agreement granting Nippon Gene access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

1 Jul 2021

The impact of COVID-19 on dialysis patients

In this interview, News-Medical speaks to Professor Simon Davies and Dr. Raymond Vanholder about the impact of COVID-19 on kidney dialysis patients.

1 Jul 2021

FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, today announced the launch of the “THE ANTIBODY SERIES” - a 1-day conference bringing together top experts in the antibody field to explore the latest innovation within antibody drug discovery.

From FairJourney Biologics S.A. 1 Jul 2021

New malaria vaccine is undergoing Phase 1 trials but current results show it provides strong and long-lasting protection

A new malaria vaccine could be the breakthrough in developing an effective and lasting treatment.

1 Jul 2021

Study shows wearing facial masks do not impose any limitations during physical exercise

A new study demonstrates that wearing an N95 respirator or cloth mask does not limit the capacity to conduct physical exercise among adults.

1 Jul 2021

People with COVID-19 frequently infect their pets and cats are particularly at risk

Previous studies have shown that cats and dogs can catch COVID-19 from their owners, but new research is attempting to understand how and why this occurs.

1 Jul 2021

Zinc-embedded polyamides inactivate SARS-CoV-2 and influenza A

The researchers show that the fabric retains its virus-inactivating property and stable zinc content over 50 standardized washes.

1 Jul 2021

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Researchers at Texas Biomedical Research Institute (Texas Biomed) have narrowed down the proteins enabling SARS-CoV-2 to cause disease.

1 Jul 2021

COVID-19 burden consistently hits Latino Californians, shows study

Researchers from the UCLA Fielding School of Public Health have found the burden of the COVID-19 pandemic has consistently hit Latino Californians with case rates roughly three times that of whites in all age groups.

1 Jul 2021

Frequent testing improves the detection of SARS-CoV-2

Detecting SARS-CoV-2, the virus that causes COVID-19, improves with regularity of testing, whether using rapid antigen tests or PCR molecular tests

1 Jul 2021

Majority of people were unprepared and did not have a pandemic plan, survey reveals

Researchers point out that if these healthy individuals had a challenging time absorbing COVID-related information, then such challenges may be even greater in people with limited educational opportunities or with neurocognitive disorders, such as Alzheimer's disease or a brain injury, due to low health literacy and impaired memory.

1 Jul 2021

Individuals who contract COVID-19 after vaccination are likely to have a lower viral load

Individuals who contract COVID-19 even after vaccination are likely to have a lower viral load, experience a shorter infection time and have milder symptoms than people who are unvaccinated, according to research that includes data from ongoing University of Arizona Health Sciences studies.

1 Jul 2021

Research shows COVID-19-mRNA vaccine efficiency against coronavirus variants

A new Finnish study shows that 180 health care workers who had received two doses of the Pfizer and Biontech vaccine have very good antibody responses against the SARS-CoV-2 virus. The immune response was as strong against the alpha variant (formerly the UK variant) but was somewhat decreased against the beta variant (formerly the South Africa variant).

1 Jul 2021

COVID mRNA vaccines induce antibodies against three SARS-CoV-2 variants

Researchers at the Institute of Biomedicine, the University of Turku in Finland showed that the blood of BNT162b2-vaccinated health care workers effectively neutralized the SARS-CoV-2 variant with the D614G substitution and the B.1.1.7 variant (Alpha variant) after the second dose.

1 Jul 2021

Disease/Infection News

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

FDA's new Cyclospora Prevention, Response and Research Action Plan released

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

Study evaluates neutralizing antibody responses elicited by the Pfizer/BioNTech COVID-19 vaccine

Can age, sex, BMI or blood group influence the immunogenicity of the Pfizer/BioNTech COVID-19 vaccine?

Could peridomestic mammals act as zoonotic reservoirs for SARS-CoV-2?

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

The impact of COVID-19 on dialysis patients

FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

New malaria vaccine is undergoing Phase 1 trials but current results show it provides strong and long-lasting protection

Study shows wearing facial masks do not impose any limitations during physical exercise

People with COVID-19 frequently infect their pets and cats are particularly at risk

Zinc-embedded polyamides inactivate SARS-CoV-2 and influenza A

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

COVID-19 burden consistently hits Latino Californians, shows study

Frequent testing improves the detection of SARS-CoV-2

Majority of people were unprepared and did not have a pandemic plan, survey reveals

Individuals who contract COVID-19 after vaccination are likely to have a lower viral load

Research shows COVID-19-mRNA vaccine efficiency against coronavirus variants

COVID mRNA vaccines induce antibodies against three SARS-CoV-2 variants

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News